CVS Health's Omnicare Enters Asset Purchase Agreement with GenieRx

Omnicare continues court-supervised process while delivering enhanced value to customers.

Apr. 1, 2026 at 9:55pm

Omnicare, LLC, a subsidiary of CVS Health (NYSE: CVS), has announced that it has entered into an asset purchase agreement with GenieRx Holdings LLC, a joint partnership between private equity firms. The agreement is part of Omnicare's ongoing court-supervised process as it continues to deliver enhanced value to its customers.

Why it matters

The asset purchase agreement with GenieRx is a significant development in Omnicare's court-supervised process, which aims to restructure the company and ensure it can continue providing high-quality services to its customers. As a subsidiary of the major healthcare company CVS Health, Omnicare's stability and ability to serve its customers is crucial.

The details

Under the terms of the agreement, GenieRx will acquire certain assets of Omnicare. The court-supervised process allows Omnicare to continue operating while it works to enhance the value it provides to customers. Omnicare is a leading provider of pharmacy services to long-term care facilities, assisted living communities, and other healthcare providers.

  • Omnicare announced the asset purchase agreement on April 1, 2026.

The players

Omnicare, LLC

A subsidiary of CVS Health and a leading provider of pharmacy services to long-term care facilities, assisted living communities, and other healthcare providers.

GenieRx Holdings LLC

A joint partnership between private equity firms that has agreed to acquire certain assets of Omnicare as part of the company's court-supervised process.

CVS Health (NYSE: CVS)

The parent company of Omnicare, a major healthcare company.

Got photos? Submit your photos here. ›

The takeaway

Omnicare's asset purchase agreement with GenieRx is a crucial step in the company's court-supervised process, allowing it to continue delivering enhanced value to its customers while restructuring to ensure its long-term stability and ability to serve the healthcare industry.